Literature DB >> 7068222

Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.

T M Ellis, J T Barrett.   

Abstract

Serum collected from mice experimentally infected with Bacteroides fragilis 23745 (immune serum) was analyzed for its ability to opsonize the in vitro ingestion of this organism by mouse peritoneal macrophages. B. fragilis was shown to be phagocytized most efficiently in the presence of immune serum although normal mouse serum demonstrated reduced, but significant, opsonic activity. Phagocytosis was greater in the presence of serum collected from animals inoculated twice with the organism than in the presence of serum from once-inoculated animals. The increased opsonic activity of serum from twice-inoculated animals compared to singly inoculated animals was associated with increases in immunoglobulin G1(IgG1), IgG2a, and IgG2b but not IgM. Adsorption analysis of immune serum with homologous or heterologous bacterial antigens indicated that both antibody and complement act synergistically in opsonizing B. fragilis, although either alone may effectively opsonize this organism. Further evaluation of antibody-mediated opsonization revealed that prior treatment of heat-inactivated immune serum with the reducing agent 2-mercaptoethanol caused a slight, but significant, decrease in opsonic activity, thus indicating that IgM is a minor opsonizing antibody for B. fragilis. When ingestion of a B. fragilis stock strain (23745) was compared to a recent clinical isolate (C-1), it was observed that the stock strain was more easily phagocytized in the presence of normal mouse serum, thus suggesting a possible anti-opsonic-phagocytic property of the clinical strain. In addition, the clinical isolate was phagocytized to a significantly greater degree in an aerobic than an anaerobic environment. Subsequent analysis of in vitro killing of B. fragilis 23745 by peritoneal macrophages reflected the previous results in that optimal killing occurred in the presence of immune serum, although normal serum promoted phagocytic killing to an intermediate degree. Thus, these studies implicate both antibody and complement, either alone or in combination, in the opsonization of B. fragilis. Moreover, the virulence of clinical B. fragilis strains may relate to their refractoriness to opsonization and phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068222      PMCID: PMC351136          DOI: 10.1128/iai.35.3.929-936.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  Serum bactericidal actions.

Authors:  L H MUSCHEL
Journal:  Ann N Y Acad Sci       Date:  1960-11-21       Impact factor: 5.691

3.  Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.

Authors:  C B Walker; T D Wilkins
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

4.  Complement activation by Propionibacterium acnes and Bacteroides melaninogenicus.

Authors:  K Okuda; K Yanagi; I Takazoe
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

5.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

Review 6.  Properties of the Fc receptor on macrophages.

Authors:  K J Dorrington
Journal:  Immunol Commun       Date:  1976

7.  Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.

Authors:  A B Bjornson; H S Bjornson; B P Kitko
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum.

Authors:  D A Casciato; J E Rosenblatt; R Bluestone; L S Goldberg; S M Finegold
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

9.  Participation of immunoglobulin and the alternative complement pathway in opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron.

Authors:  A B Bjornson; H S Bjornson
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

10.  Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.

Authors:  D L Kasper; A B Onderdonk; B G Reinap; A A Linberg
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

View more
  3 in total

1.  Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D Schmeling; J Mathews; P G Quie
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

2.  The pathogenic properties of Fusobacterium and Bacteroides species from wallabies and other sources.

Authors:  G R Smith; J C Oliphant; R Parsons
Journal:  J Hyg (Lond)       Date:  1984-04

3.  Indirect serum haemagglutinating antibody response to black pigmented Bacteroides during experimental pure infections in rats.

Authors:  V Pancholi; A Ayyagari; K C Agarwal
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.